Akums Drugs & Pharmaceuticals Share Price
₹596.00 -29.65 (-4.74%)
22 Jan, 2025 12:28
Start SIP in AKUMS
Start SIPPerformance
- Low
- ₹585
- High
- ₹628
- 52 Week Low
- ₹530
- 52 Week High
- ₹1,176
- Open Price₹621
- Previous Close₹626
- Volume343,730
Investment Returns
- Over 1 Month + 4.05%
- Over 3 Month -34.92%
- Over 6 Month -12.22%
- Over 1 Year -12.22%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 33.8
- PEG Ratio
- -
- Market Cap Cr
- 9,381
- P/B Ratio
- 3.3
- Average True Range
- 26.18
- EPS
- 17.41
- Dividend Yield
- 0
- MACD Signal
- -4.43
- RSI
- 49.92
- MFI
- 62.65
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹596.00
-29.65
(-4.74%)
- Bearish Moving Average 13
- Bullish Moving Average 0
- 20 Day
- ₹622.88
- 50 Day
- ₹653.10
- 100 Day
- ₹744.47
- 200 Day
- -
Resistance and Support
625.72
- R3 654.78
- R2 645.12
- R1 635.38
- S1 615.98
- S2 606.32
- S3 596.58
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-09 | Quarterly Results | |
2024-08-24 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹596 As on 22 January, 2025 | 12:14
The Market Cap of Akums Drugs & Pharmaceuticals is ₹9380.7 Cr As on 22 January, 2025 | 12:14
The P/E ratio of Akums Drugs & Pharmaceuticals is 33.8 As on 22 January, 2025 | 12:14
The PB ratio of Akums Drugs & Pharmaceuticals is 3.3 As on 22 January, 2025 | 12:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.